Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Kong

Showing results (361-370 of 380) with videos related to

Pageof 38
Sort By:
Gut|September 21, 2016
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancyBo Kong, Philipp Bruns, Nora A Behler, et al.
Hepatology Communications|May 16, 2025
Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
JCI Insight|April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtypeFelix Orben, Katharina Lankes, Christian Schneeweis, et al.
Hepatology Communications|May 23, 2024
Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomyMonica D Chow, Katherine Otersen, Andrew Wassef, et al.
Gastroenterology|July 25, 2021
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53Zhiheng Zhang, Hongzhen Li, Yibin Deng, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
British Journal of Cancer|January 25, 2025
Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migrationFang Cheng Wong, Sebastian R Merker, Lisa Bauer, et al.
BMC Urology|March 29, 2018
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective studyLe-Ye He, Ming Zhang, Zhi-Wen Chen, et al.
Oncogene|August 8, 2025
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer networkXiaoping Zou, Shuang Nie, Jing Cao, et al.
Pageof 38

Showing results (361-370 of 380) with videos related to

Sort By:
Pageof 38
Gut|September 21, 2016
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancyBo Kong, Philipp Bruns, Nora A Behler, et al.
Hepatology Communications|May 16, 2025
Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
JCI Insight|April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtypeFelix Orben, Katharina Lankes, Christian Schneeweis, et al.
Hepatology Communications|May 23, 2024
Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomyMonica D Chow, Katherine Otersen, Andrew Wassef, et al.
Gastroenterology|July 25, 2021
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53Zhiheng Zhang, Hongzhen Li, Yibin Deng, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
British Journal of Cancer|January 25, 2025
Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migrationFang Cheng Wong, Sebastian R Merker, Lisa Bauer, et al.
BMC Urology|March 29, 2018
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective studyLe-Ye He, Ming Zhang, Zhi-Wen Chen, et al.
Oncogene|August 8, 2025
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer networkXiaoping Zou, Shuang Nie, Jing Cao, et al.
Pageof 38